One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis

BACKGROUND: Mesalazine (Asacol) is still widely prescribed in divided doses for ulcerative colitis (UC), despite evidence that adherence is improved by once-daily (OD) prescribing. We aimed to investigate whether OD Asacol was as effective as three times (TDS) daily dosing, and to evaluate the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawthorne, A Barney, Stenson, Rachel, Gillespie, David, Swarbrick, Edwin T, Dhar, Anjan, Kapur, Kapil C, Hood, Kerry, Probert, Chris SJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2012
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746130/
https://www.ncbi.nlm.nih.gov/pubmed/22081522
http://dx.doi.org/10.1002/ibd.21938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746130/
https://www.ncbi.nlm.nih.gov/pubmed/22081522
http://dx.doi.org/10.1002/ibd.21938

Ejemplares similares